Efficacy of Malarone(®) in dogs naturally infected with Babesia gibsoni
- PMID: 24909969
- PMCID: PMC4197161
- DOI: 10.1292/jvms.14-0139
Efficacy of Malarone(®) in dogs naturally infected with Babesia gibsoni
Abstract
The efficacy of Malarone(®) alone and in combination with doxycycline (DOXY) against Babesia gibsoni infections was examined in 8 dogs. In all dogs except one treated with Malarone(®), parasitemia decreased, and anemia improved soon after initiation of treatment. However, 3 of 4 dogs treated with Malarone(®) relapsed, and relapse was inhibited in 2 of 4 dogs treated with Malarone(®) and DOXY. All relapsed dogs responded well to the second treatment, but 1 dog relapsed again and did not respond to the third treatment. Malarone(®) may be useful for acute stage of B. gibsoni infections, and at least second repeating treatment might be effective.
Figures
Similar articles
-
The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.Vet Parasitol. 2013 Nov 8;197(3-4):527-33. doi: 10.1016/j.vetpar.2013.06.006. Epub 2013 Jun 11. Vet Parasitol. 2013. PMID: 24075418 Clinical Trial.
-
Successful Transmammary Treatment of Babesia gibsoni Infection in Newborn Puppies after the Administration of Malarone®, Azithromycin, and Artesunate to a Lactating Dam.Pathogens. 2024 Jul 3;13(7):562. doi: 10.3390/pathogens13070562. Pathogens. 2024. PMID: 39057789 Free PMC article.
-
First molecular identification of Babesia gibsoni in dogs from Slovakia, central Europe.Ticks Tick Borne Dis. 2016 Feb;7(1):54-59. doi: 10.1016/j.ttbdis.2015.08.004. Epub 2015 Aug 10. Ticks Tick Borne Dis. 2016. PMID: 26304014
-
Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.Am J Trop Med Hyg. 1999 Apr;60(4):533-41. doi: 10.4269/ajtmh.1999.60.533. Am J Trop Med Hyg. 1999. PMID: 10348225 Review.
-
Antiprotozoal treatment of canine babesiosis.Vet Parasitol. 2018 Apr 30;254:58-63. doi: 10.1016/j.vetpar.2018.03.001. Epub 2018 Mar 7. Vet Parasitol. 2018. PMID: 29657012 Review.
Cited by
-
Kinetic Characterization and Inhibitor Screening of Pyruvate Kinase I From Babesia microti.Front Microbiol. 2021 Sep 16;12:710678. doi: 10.3389/fmicb.2021.710678. eCollection 2021. Front Microbiol. 2021. PMID: 34603237 Free PMC article.
-
Case report: First autochthonous Babesia vulpes infection in a dog from Italy.Front Vet Sci. 2025 Feb 19;12:1498721. doi: 10.3389/fvets.2025.1498721. eCollection 2025. Front Vet Sci. 2025. PMID: 40046425 Free PMC article.
-
Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment.Vet Med (Auckl). 2015 Apr 10;6:119-128. doi: 10.2147/VMRR.S60431. eCollection 2015. Vet Med (Auckl). 2015. PMID: 30155438 Free PMC article. Review.
-
Clinical Efficacy and Safety of Malarone®, Azithromycin and Artesunate Combination for Treatment of Babesia gibsoni in Naturally Infected Dogs.Animals (Basel). 2022 Mar 11;12(6):708. doi: 10.3390/ani12060708. Animals (Basel). 2022. PMID: 35327106 Free PMC article.
-
Cytauxzoon felis cytochrome b gene mutation associated with atovaquone and azithromycin treatment.J Vet Intern Med. 2020 Nov;34(6):2432-2437. doi: 10.1111/jvim.15935. Epub 2020 Nov 4. J Vet Intern Med. 2020. PMID: 33146909 Free PMC article.
References
-
- Farwell G. E., Legrand E. K., Cobb C. C.1982. Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J. Am. Vet. Med. Assoc. 180: 507–511 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources